SOURCE: The Bedford Report

The Bedford Report

March 28, 2011 08:16 ET

Drug Retailers Search for New Revenue Drivers

The Bedford Report Provides Analyst Research on Rite Aid & Walgreen Company

NEW YORK, NY--(Marketwire - March 28, 2011) - With unemployment numbers remaining high and discretionary spending still low, drug retailers have struggled to regain their footing following the recession. Industry heavyweights such as Rite Aid and Walgreen have posted significant declines in their pharmacy segments as the outbreak of generic drugs continues to chew into their respective top lines. In order to offset a drop in pharmacy revenues, drug stores have begun to search for alternative revenue sources. The Bedford Report examines the outlook for companies in the Drug Store Industry and provides research reports on Rite Aid Corporation (NYSE: RAD) and Walgreen Company (NYSE: WAG). Access to the full company reports can be found at:

Last week Walgreen announced that it signed a merger agreement to acquire the online retailer for about $409 million. The acquisition will add about 60,000 products to Walgreen's online offering. is one of the largest online health and beauty retailers, and Walgreen explains that those products are an important part of its growth strategy.

"Our acquisition of today significantly accelerates our online strategy to leverage the best community store network in America by becoming the most convenient choice for health and daily living needs whether customers shop online or in our stores," said Walgreen's chief executive, Greg Wasson.

The Bedford Report releases regular market updates on the Drug Store Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at and get exclusive access to our numerous analyst reports and industry newsletters.

In recent quarters, both Walgreen and industry peer Rite Aid have posted diminishing revenues in their respective pharmacy segments. Rite Aid has been very vocal on blaming the surge in generic drugs for its revenue slump. For the month of February Rite Aid reported that same-store sales increased 0.9 percent in the pharmacy segment. At the front end of the store, same-store sales grew 1.1 percent.

The Bedford Report provides Analyst Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned publicly traded companies. The Bedford Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at

Contact Information